Share

October 2022; 12 (5) Research Article

Online vs Face-to-Face Administration of Impulse Control Disorder Questionnaires in Parkinson Disease

Does Method Matter?

Bonnie M. Scott, Robert S. Eisinger, Revath Sankar, Jared F. Benge, Robin C. Hilsabeck, Michael S. Okun, Aysegul Gunduz, Dawn Bowers
First published August 31, 2022, DOI: https://doi.org/10.1212/CPJ.0000000000200074
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
32

Share

Article Information

vol. 12 no. 5 e93-e97
DOI: 
https://doi.org/10.1212/CPJ.0000000000200074
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received February 24, 2022
  • Accepted July 18, 2022
  • First Published August 31, 2022.

Article Versions

Copyright & Usage: 
© 2022 American Academy of Neurology

Author Disclosures

    1. Bonnie M. Scott, PhD,
    2. Robert S. Eisinger, MD, PhD,
    3. Revath Sankar,
    4. Jared F. Benge, PhD,
    5. Robin C. Hilsabeck, PhD,
    6. Michael S. Okun, MD,
    7. Aysegul Gunduz, PhD and
    8. Dawn Bowers, PhD
  1. Bonnie M. Scott, PhD,
    2. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Robert S. Eisinger, MD, PhD,
    3. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH/NCATS Clinical and Translational Science Awards (Award Numbers UL1TR001427, KL2TR001429, and TL1TR001428), NINDS Award Number F30NS111841

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Revath Sankar,
    4. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Jared F. Benge, PhD,
    5. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. The Clinical Neuropsychologist, Consulting Editor, 2019-<br>Present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1) National Institutes on Aging, 1R01AG077017-01, Co-I, 2022-<br>Present

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1)Alzheimer's Association, AARG-22-924771, PI, 2022-Present<br>(2)Alzheimer's Association, 2019-AARF-641693, Mentor, 2019-<br>2021

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Robin C. Hilsabeck, PhD,
    6. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. The Clinical Neuropsychologist, Culture and Gender Department <br>Editor, 2018-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. Board Certification in Clinical Neuropsychology: A Guide to <br>Becoming ABPP/ABCN Certified Without Sacrificing Your Sanity <br>(2nd Ed). Oxford University Press, 2019.<br><br>Essentials of WMS-IV Assessment. John Wiley & Sons, Inc., <br>2011

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Austin FC

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Functional Neuromodulation

    Research Support, Government Entities:

    1. National Institutes of Health/National Institute on Aging, <br>Principle Investigator, 2021-2023<br><br>Texas Alzheimer's Research and Care Consortiumm, Site <br>Principle Investigator, 2018-2023

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Alzheimer's Association

    Stock/Stock Options/Board of Directors Compensation:

    1. Syneous Health

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Clark Hill, consultant, 2022

  6. Michael S. Okun, MD,
    7. Scientific Advisory Boards:

    1. Parkinson's Foundation<br>Tourette Association of America<br>JAMA Neurology Associate Editor<br>NEJM Journal Watch Associate Editor

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. No industry honoraria <br>Peerview CME, Prime, Medscape<br>CME courses on movement disorders<br>Vanderbilt University educational, movement disorders<br>society, AAN, MDS

    Editorial Boards:

    1. Tremor and Hyperkinetic Disorders 2012-present<br>Movement Disorders, 2015-2017<br>NEJM Journal Watch 2015-present<br>JAMA Neurology Associate Editor 2017-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. Ultimate Neurology Review (2007- present, DEMOS), <br>Parkinson's Disease <br>(2010, <br>Pending and not received), The Dystonia Patient and Ask <br>the <br>Expert (DEMOS, <br>royalties donated).<br>Parkinson's treatment-10 secrets to a happier life and <br>10<br>Breakthrough Therapies for PD (2013-<br>present Amazon, Books for Patients, and Smashwords).<br>Ending Parkinson's Disease (Public Affairs)<br>Living with Parkinson's Disease (Robert Rose)

    Employment, Commercial Entity:

    1. Medscape/WebMD CME, Vanderbilt educational, Prime,<br>Peerview, NEJM Journal Watch, <br>Delaware Media, CME courses on movement disorders, 2007-<br>2018

    Consultancies:

    1. Medical Advisor, Parkinson's Foundation

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. PF Medical Advisor

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH

    Research Support, Academic Entities:

    1. NIH

    Research Support, Foundations and Societies:

    1. NPF, PF, Michael J. Fox, TSA, TAA, Bachmann-Strauss, NIH

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Aysegul Gunduz, PhD and
    8. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. (1) Frontiers in Neuroprosthetics, Associate Editor, 2018-present.

    Patents:

    1. (1) Closed loop bilateral deep brain stimulation in bidirectional devices.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Pr8ceedings:

    1. NONE

  8. Dawn Bowers, PhD
    9. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1) NIH/NIA, R01-AG064587, MPI, 2019-2024<br>2) NIH/NIA, R01-AG1057764, Co-I, 2019-2023<br>3) NIH/NINDS, 2T32-NS82168, MPI, 2015-2024<br>4) NIH/NICDS, R01-HD091658, Co-I, 2017-2022<br>5) NIH/NINDS, UH3-NS095553, Co-I, 2016-2021<br>6) NIH/NINDS, R01-NS096008, Co-I, 2016-2021

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1) Parkinson Foundation<br>2) McKnight Research Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Clinical and Health Psychology (BMS, DB), University of Florida, Gainesville, FL; Department of Neurology (BMS, RS, JFB, RCH), Dell Medical School, University of Texas at Austin, Austin, TX; Department of Neuroscience (RSE, AG), Norman Fixel Institute of Neurological Diseases, University of Florida; Department of Neurology (MSO), Norman Fixel Institute of Neurological Diseases, University of Florida; and J. Crayton Pruitt Department of Biomedical Engineering (AG), University of Florida, Gainesville, FL.
  1. Correspondence
    Dr. Scott bonnie.scott{at}austin.utexas.edu
View Full Text

Article usage

Article usage: August 2022 to April 2023

AbstractFullPdfSource
Aug 202211001Highwire
Sep 202245305Highwire
Oct 20224332615Highwire
Nov 202230064Highwire
Dec 202211256Highwire
Jan 20239501Highwire
Feb 20238820Highwire
Mar 202310400Highwire
Apr 20234710Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me